Each of our companies started off small: two people, a vision and determination to change the way healthcare worked. At IMS, it was creating information about healthcare activity that never existed before. For Quintiles, it was introducing data science to drug development.
We continue to have bold ambitions.
Technology solutions to power your competitive differentiation and accelerate your business model transformation
Our clinical and commercial
Our DataThe world’s largest and most diverse set of healthcare information, including privacy protected, anonymized patient level data to provide granularity
Our PeopleAn uncommon blend of clinical, commercial, data and technology experts all working together to create solutions that cut across disciplines
In this report we highlight various aspects of the market for medicines in the U.S—spanning aggregate spending, key medicine categories, volumes, patient cost exposure, as well as our outlook to 2021. The report seeks to provide appropriate context and perspective around the complex factors that drive the level of spending on medicines and their role in our healthcare system.
We cannot just claim to bring clinical, commercial and real-world insights together because we put them into one company. We have to make it happen. And it is by connecting our capabilities in new ways throughout the product lifecycle that we do.